Differential influence of vemurafenib and dabrafenib on patient lymphocytes despite similar clinical efficacy in melanoma

P074

  • Schilling, B.
  • Sondermann, W.
  • Zhao, F.
  • Griewank, K.
  • Livingstone, E.
  • Sucker, A.
  • Zelba, H.
  • Weide, B.
  • Trefzer, U.
  • Wilhelm, T.
  • Loquai, C.
  • Berking, C.
  • Hassel, J. C.
  • Kähler, K. C.
  • Utikal, J.
  • Al Ghazal, P.
  • Gutzmar, R.
  • Goldinger, S. M.
  • Zimmer, L.
  • Paschen, A.
  • Hillen, U.
  • Schadendorf, D.

  • 1Department of Dermatology, University Hospital Essen, Essen, Germany; 2University of Tübingen, University Medical Center, Tübingen, Germany; 3Department of Dermatology, Venerology and Allergy, Charit Universitätsmedizin Berlin, Berlin, Germany; 4Department of Dermatology, University of Mainz, Mainz, Germany; 5Department of Dermatology and Allergology, Ludwig-Maximilian University, Munich, Germany; 6Department of Dermatology, Heidelberg University Hospital, Heidelberg, Germany; 7Department of Dermatology, Venerology and Allergology, University of Schleswig-Holstein Hospital, Kiel, Germany; 8German Cancer Research Center (DKFZ), Skin Cancer Unit, Heidelberg, Germany; 9Department of Dermatology, Venereology and Allergology, University Medical Centre Mannheim, Mannheim, Germany; 10Department of Dermatology and Allergy, Hannover Medical School, Hannover, Germany; 11Department of Dermatology, University Hospital Zürich, Zürich, Switzerland

Experimental Dermatology 23(3):p e14, March 2014.
Copyright © 2014 John Wiley & Sons, Ltd